Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor-Reference-Cited by-同舟云学术

Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

Published:2010-05-19 Issue:2 Volume:225 Page:585-592
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Nuche-Berenguer Bernardo,Portal-Núñez Sergio,Moreno Paola,González Nieves,Acitores Alicia,López-Herradón Ana,Esbrit Pedro,Valverde Isabel,Villanueva-Peñacarrillo María L.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference47 articles.

1. Exendin-4 agonist and exendine(9-39) amide antagonist of the GLP-1(7-36) amide effects in liver and muscle;Alcántara;Arch Biochem Biophys,1997

2. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle;Arnés;Int J Mol Med,2008

3. Osteoblasts-derived cells express functional glucose-dependent insulinotropic peptide receptors;Bollag;Endocrinology,2000

4. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein dye binding;Bradford;Anal Biochem,1976

5. Perspective potential role of pancreatic and enteric hormones in regulating bone turnover;Clowes;J Bone Miner Res,2005

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Fragility in Diabetes and its Management: A Narrative Review;Drugs;2024-08-05

2. Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models;Peptides;2024-07

3. Gut hormones and bone homeostasis: potential therapeutic implications;Nature Reviews Endocrinology;2024-06-10

4. Liraglutide, a glucagon-like peptide-1 receptor agonist, inhibits bone loss in an animal model of osteoporosis with or without diabetes;Frontiers in Endocrinology;2024-05-29

5. Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis;Frontiers in Pharmacology;2024-04-25